Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristopher Bragg

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Neurobiology of Disease|December 27, 2016
X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa BChristine A Vaine, David Shin, Christina Liu, et al.
Biomolecules|May 28, 2022
DYT-<i>PRKRA</i> Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon InductionLauren S Vaughn, Kenneth Frederick, Samuel B Burnett, et al.
Research Square|May 15, 2024
SAK3 confers neuroprotection in the neurodegeneration model of X-linked Dystonia-ParkinsonismShivani Aryal, Shawei Chen, Kyle F Burbach, et al.
Biomaterials|January 16, 2022
Using genetically modified extracellular vesicles as a non-invasive strategy to evaluate brain-specific cargoDavid Rufino-Ramos, Sevda Lule, Shadi Mahjoum, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2024
ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP)Jimi L Rosenkrantz, J Elias Brandorff, Sanaz Raghib, et al.
Journal of Neurochemistry|May 22, 2009
Phosphorylation of the homer-binding domain of group I metabotropic glutamate receptors by cyclin-dependent kinase 5Lianna R Orlando, Ramses Ayala, Lauren R Kett, et al.
Nature Communications|May 5, 2026
Correction of the molecular phenotype of X-linked Dystonia-Parkinsonism reveals a non-canonical function of BRD4Simona Capponi, Sandra Ehret, Zeynep Camgöz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 18, 2023
Tracking human neurologic disease status in mouse brain/plasma using reporter-tagged, EV-associated biomarkersKatia E Maalouf, Christine A Vaine, Dawn M Frederick, et al.
Disease Models & Mechanisms|January 16, 2016
Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cellsNaoto Ito, William T Hendriks, Jyotsna Dhakal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 28, 2025
Intracellular and Extracellular Vesicle miRNA Signatures in Human iPSC-Derived Neural Stem Cells and Floor Plate ProgenitorsLilian Cruz, Frederico Moraes Ferreira, Camila Miranda Lopes-Ramos, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Neurobiology of Disease|December 27, 2016
X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa BChristine A Vaine, David Shin, Christina Liu, et al.
Biomolecules|May 28, 2022
DYT-<i>PRKRA</i> Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon InductionLauren S Vaughn, Kenneth Frederick, Samuel B Burnett, et al.
Research Square|May 15, 2024
SAK3 confers neuroprotection in the neurodegeneration model of X-linked Dystonia-ParkinsonismShivani Aryal, Shawei Chen, Kyle F Burbach, et al.
Biomaterials|January 16, 2022
Using genetically modified extracellular vesicles as a non-invasive strategy to evaluate brain-specific cargoDavid Rufino-Ramos, Sevda Lule, Shadi Mahjoum, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2024
ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP)Jimi L Rosenkrantz, J Elias Brandorff, Sanaz Raghib, et al.
Journal of Neurochemistry|May 22, 2009
Phosphorylation of the homer-binding domain of group I metabotropic glutamate receptors by cyclin-dependent kinase 5Lianna R Orlando, Ramses Ayala, Lauren R Kett, et al.
Nature Communications|May 5, 2026
Correction of the molecular phenotype of X-linked Dystonia-Parkinsonism reveals a non-canonical function of BRD4Simona Capponi, Sandra Ehret, Zeynep Camgöz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 18, 2023
Tracking human neurologic disease status in mouse brain/plasma using reporter-tagged, EV-associated biomarkersKatia E Maalouf, Christine A Vaine, Dawn M Frederick, et al.
Disease Models & Mechanisms|January 16, 2016
Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cellsNaoto Ito, William T Hendriks, Jyotsna Dhakal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 28, 2025
Intracellular and Extracellular Vesicle miRNA Signatures in Human iPSC-Derived Neural Stem Cells and Floor Plate ProgenitorsLilian Cruz, Frederico Moraes Ferreira, Camila Miranda Lopes-Ramos, et al.
Pageof 5